ORIX Corporation
NYSE:IXFinancial - Credit Services
+$0.45 today
- Market cap
- $36.76B
- Beta
- 0.73
- P/E (TTM)
- 15.7
- EPS (TTM)
- $412.82
- Dividend yield
- 2.42%
Volume 0.30M
Average 0.36M
IX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
ORIX CorporationNYSE: IX
Cash & Equivalents · Q1 FY2027 · quarter ended Jun 2026
Cash & equivalents falls 19.7% from a year ago
Cash & equivalents stood at ¥968.92B at the end of Q1 FY2027, down 19.7% from a year earlier and down 33.5% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Cash & equivalents amounted to 5.3% of total assets at the end of Q1 FY2027, down 1.8 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -19.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
JPY · from the balance sheet
- Latest · FY2026
- 1.46T JPY
- Year-over-year change
- +20.8%
- 4-year CAGR
- +11.2%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 1.46T | +20.8% |
| FY2025 | 2025-03-31 | 1.21T | +16.8% |
| FY2024 | 2024-03-31 | 1.03T | -16.2% |
| FY2023 | 2023-03-31 | 1.23T | +29.0% |
| FY2022 | 2022-03-31 | 954.83B | — |
Cash & Equivalents vs competitors
How IX compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -19.7% is the 5th highest of 6, against a peer median of -2.1%.
- Cash & equivalents amounts to 5.3% of total assets for IX, versus a peer median of 3.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | ¥968.92B JPY | -19.7% | +5.8% | 5.3% | |
| Sep 2026 | $15.9B USD | -2.1% | +13.3% | 13.0% | |
| Jun 2026 | $3.13B USD | +47.3% | +51.3% | 5.1% | |
| Mar 2026 | $621M USD | -3.3% | +11.1% | 1.3% | |
| Sep 2026 | $203.16M USD | +56.0% | +2.2% | 3.7% | |
| Mar 2026 | $79.5M USD | -62.7% | +32.8% | 3.9% | |
| Peer median (excluding IX) | — | -2.1% | +13.3% | 3.9% | |
Competitors are the stored peer set for IX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 954.83B | 1.23T | 1.03T | 1.21T | 1.46T |
| Short-term Investments | 4.2B | 4.37B | 2.03B | 2.61T | 0 |
| Net Receivables | 5.26T | 5.42T | 5.53T | 411.01B | 4.61T |
| Inventory | 139.56B | 169.02B | 227.36B | 0 | 0 |
| Other Current Assets | 184B | 189.32B | 223.23B | 115.41B | 0 |
| Total Current Assets | 6.54T | 7.02T | 7.01T | 4.34T | 6.07T |
| Property, Plant & Equipment (Net) | 910.01B | 973.06B | 1.03T | 2.13T | 986.5B |
| Goodwill | 488.86B | 627.68B | 631.77B | 0 | 0 |
| Intangible Assets | 473.88B | 590.41B | 612.67B | 7.67B | 0 |
| Long-term Investments | 3.64T | 3.76T | 4.42T | 5.97T | 6.8T |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.2T | 2.29T | 2.61T | 4.42T | 4.23T |
| Total Non-current Assets | 7.72T | 8.25T | 9.29T | 12.53T | 12.01T |
| Total Assets | 14.26T | 15.29T | 16.32T | 16.87T | 18.08T |
| Account Payables | 291.42B | 366.85B | 362.5B | 339.79B | 0 |
| Short-term Debt | 447.82B | 512.12B | 577.82B | 549.68B | 574.72B |
| Tax Payables | 461.18B | 384.78B | 65.53B | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 212.86B | 93.25B | 157.49B | 2.45T | 0 |
| Total Current Liabilities | 952.11B | 972.21B | 1.1T | 3.39T | 574.72B |
| Long-term Debt | 4.43T | 5.21T | 5.63T | 5.73T | 5.99T |
| Deferred Tax Liabilities | 0 | 0 | 0 | 525.63B | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.24T | 5.2T | 5.31T | 3.04T | 6.87T |
| Total Non-current Liabilities | 9.95T | 10.7T | 11.2T | 9.3T | 12.86T |
| Total Liabilities | 10.9T | 11.67T | 12.3T | 12.69T | 13.44T |
| Common Stock | 221.11B | 221.11B | 221.11B | 221.11B | 222.07B |
| Retained Earnings | 2.91T | 3.05T | 3.26T | 3.35T | 3.52T |
| Accumulated OCI | (16.04B) | 156.14B | 357.15B | 341.3B | 607.49B |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 243.05M |
| Minority Interest | 109.98B | 71.66B | 83.14B | 82B | 141.92B |
| Total Equity | 3.37T | 3.62T | 4.02T | 4.17T | 4.64T |
| Total Debt | 5.16T | 6.01T | 6.46T | 6.28T | 6.57T |
| Net Debt | 4.2T | 4.78T | 5.43T | 5.08T | 5.11T |
ORIX Corporation
NYSE:IX
Intrinsic Alpha fair value
Locked
Current Price
$33.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.